Department of Health issues warning on spray products Lotrimin and Tinactin manufactured by Bayer Consumer Health

TThe Department of Health and Human Services (MoHHS), in response to an advisory from the United States Food and Drug Administration (FDA), advises all local health facilities, other local providers, and the general public to ” discontinue the sale and / or use of specific Lotrimin. ® AF and Tinactin® antifungal spray products manufactured by Bayer Consumer Health.

Lotrimin® AF and Tinactin® are used to treat fungal infections that cause ringworm of the feet, the skin condition known as athlete’s foot.

The advisory results from a voluntary recall due to the presence of benzene (a human carcinogen) – a substance that could potentially cause cancer, depending on the level and extent of exposure – in these products.

The impacted products are:
Product Description: Lotrimin Spray® AF and Tinactin Spray®
Lotrimin® Antifungal (AF) Athlete’s Foot Powder Spray
Lotrimin® Anti-Fungal Jock Itch (AFJI) Powder Spray for Athlete’s Foot
Lotrimin® Antifungal (AF) Powdered Athlete’s Foot Deodorant Spray
Lotrimin® AF Liquid Athlete’s Foot Spray
Lotrimin® AF Athlete’s Foot Daily Prevention Powder Deodorant Spray
Tinactin® Jock Itch (JI) Powder Spray
Tinactin® Athlete’s Foot Powder Deodorant Spray
Tinactin® Athlete’s Foot Powder Spray
Tinactin® Liquid Athlete’s Foot Spray

According to a press release from the Department of Health, based on the recall, benzene is not an ingredient in any of the spray products.

The Department of Health therefore urges all local health facilities and other local suppliers to immediately stop supplying the brands listed above, notify overseas suppliers, and quarantine all remaining stocks of the identified brands for possible future use. disposal by the Department of Environmental Health.

In addition, the ministry wishes to implore consumers to stop using the affected products and to contact their respective local suppliers.

Consumers can contact the Department of Environmental Health at 338-2142 for more information on the best way to dispose of these spray products.

Additionally, consumers should contact their physician or health care provider if they have any questions, concerns, or have encountered any problems while using these spray products. Consumers / patients should also be advised to report any side effects via the MoHHS Adverse Drug Reaction Form available at

Ensuring public health safety is the top priority of MoHHS and will therefore continue to monitor this situation as investigations continue.

For more information, please contact the ministry at 338-3072.

Source link

Leave A Reply

Your email address will not be published.